Blog

NeuroSense strives to make science, research and clinical development accessible to patients, family members, caregivers, and the scientific community. Therefore, we have created a blog that will touch upon different aspects of drug development, neurodegenerative diseases, research and development, science, biotech and business. Check this page regularly for informative and timely updates. 

Kate Morgan & the NRSN team

“The feeling of successfully navigating the regulatory landscape and achieving drug approval is indescribable”

Kate Morgan & the NRSN team

“R&D companies like NeuroSense are doing the greatest thing any company can do. Financially, they are taking an enormous risk with a drive to change the world.

Kate Morgan & the NRSN team

“Seeing how an individual living with ALS could benefit so much from the technology I helped create, I was inspired to dedicate myself to finding a remedy for ALS and other neurodegenerative diseases”.

Kate Morgan & the NRSN team

“The most rewarding aspect of leading NeuroSense is hearing how we have improved people’s lives”

NeuroSense intern team

“Today I consider myself the luckiest man on the face of the earth.” — Lou Gehrig Yankee stadium retirement speech, July 4, 1939.

Dr. Shiran Zimri

Motor neuron diseases (MNDs) are a debilitating subset of diseases causing progressive neuronal destruction and eventual loss of muscular function

Join Our Newsletter

Skip to content